What Makes a Good Leader?
Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.
As cases of COVID-19 began spiking on the West Coast of the...
Online Exclusives
Early Results Show Moderna’s COVID-19 Vaccine is 95% Effective
Moderna shared early findings that show its experimental coronavirus vaccine was 94.5% effective at preventing COVID-19.
In a study of 30,000 people, 95 developed symptomatic...
FDA Grants Emergency Use Authorization to Bamlanivimab for COVID-19
The FDA has granted emergency use authorization to bamlanivimab, an antibody treatment for COVID-19.
“It’s a great day for science and medicine,” said Daniel Skovronsky,...
News
From the Blood Journals
Lower Socioeconomic Status Associated With Worse Post-Transplant Survival in Children With...
According to an analysis of data from the Center for International Blood and Marrow Transplant Research (CIBMTR), children with cancer who have Medicaid insurance...
How Common Is Venous Thromboembolism in Patients Hospitalized With COVID-19?
Reports have suggested that venous thromboembolism (VTE) is a frequent complication of COVID-19 infection, and patients are at an increased thrombotic risk even with...
Multimedia
Constantine Tam: Comparing Zanubrutinib With Ibrutinib in Waldenström Macroglobulinemia
Treatment with zanubrutinib resulted in a higher combined complete response and very good partial response rate than therapy with ibrutinib in patients with Waldenström...
John Kuruvilla: Pembrolizumab in Relapsed/Refractory Classic Hodgkin Lymphoma
Treatment with pembrolizumab prolonged progression-free survival more than brentuximab vedotin, including in patients ineligible for transplant. Dr. Kuruvilla discusses results from the phase III...
Meletios Dimopoulos: Weekly SVd Improved PFS in Relapsed/Refractory Myeloma
Once weekly combination treatment with selinexor, bortezomib, and dexamethasone led to an approximately 4-month improvement in progression-free survival compared with bortezomib plus dexamethasone. Meletios...
Shaji Kumar: Comparing KRd With VRd in Newly Diagnosed Myeloma
Initial treatment with carfilzomib, lenalidomide, and dexamethasone was not associated with greater improvements in progression-free survival compared with bortezomib, lenalidomide, and dexamethasone. Shaji Kumar,...
On Location
Take Note: Virtual Format Provides Access to Thousands of High-Quality Abstracts
ASH Secretary Robert Brodsky, MD, from Johns Hopkins University School of Medicine, has been involved...
When Virtual Becomes the Reality
A behind-the-scenes look at how the American Society of Hematology reworked its annual meeting for...
2020 ASH Annual Meeting Preview: Conversations With Co-Chairs
Education Program Co-chairs
Scientific Program Co-chairs
How are speakers being asked to modify their presentations for a...
Rare Conditions of Great Importance in Differential Diagnoses
Hematologists are confronted by an array of complex and somewhat obscure conditions. As a follow-up...
Balancing the Yin and Yang of Autoimmunity and Immunodeficiencies
As part of this year’s Education Program, experts will lead a case-based discussion of the...
Challenges With TCRs, CAR T Cells, and Other Cell Therapies
As indications for allogeneic hematopoietic cell transplantation (HCT) and adoptive cellular therapies are expanding, more...
Latest Headlines
ASH Directions
ASH Announces Executive Committee Election Results, New Clinical Practice Guidelines, and more
The Votes Are In! ASH Announces Executive Committee Election Results
The American Society of Hematology (ASH) has announced the election of four new members to...
Diversity, Equity, and Inclusion in Hematology, and more
Diversity, Equity, and Inclusion in Hematology
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and...
Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal, ASH Members Elected to...
Kwaku Ohene-Frempong Wins Assistant Secretary of Health Exceptional Service Medal
U.S. Assistant Secretary for Health Adm. Brett P. Giroir, MD, recently presented American Society of Hematology...
Remembering Patti Massicotte, Nobel Prizes Awarded for Discovery of Hepatitis C and CRISPR, and...
Remembering Patti Massicotte (1955 – 2020)
Mary Patricia “Patti” Massicotte, MD, FRCP, died on October 1, 2020 from cancer.Dr. Massicotte was Professor and Director of Clinical...
NCI Partners with Cancer Research UK, JADPRO Appoints Beth Faiman as Editor-in-Chief, and more
Fred Hutchinson Researchers Receive $3.5-Million Grant for Inherited Blood Disorder Treatment
Hans-Peter Kiem, MD, PhD, and Roland Walter, MD, PhD, from the Fred Hutchinson Cancer...
What Makes a Good Leader?
Health care leadership roles are often awarded to top clinicians and researchers, but experts say successful leaders need a different set of skills.
As cases...
Who’s Watching the Watchdog?
With most drugs now approved through one of the FDA’s expedited-review pathways, is the agency approving drugs too quickly?
In recent years, the FDA has...
Gene Therapy for Hemophilia: Progress and Setbacks
As the FDA delayed the approval of the world’s first gene therapy for hemophilia A, companies forged ahead with phase III trials to gather...